The company that greenlighted National Security Agency leaker Edward Snowden and Navy Yard shooter Aaron Alexis for security clearances stands to lose a $210 million contract with the Department of Homeland Security, the Government Accountability Office ruled in a decision released Thursday.
- Redbox Prevails in Video Privacy Protection Act Appeal
- $18 Million Punitives Award Upheld in Asbestos Case
- ‘Groundbreaking’ Ruling for Transgender Disabled Vet
- Hip Replacement Device Defendants Win Take-Nothing Verdict
- Third Circuit Eyes Dodd-Frank's Whistleblower Protection
- Blackwater Guards Vow to Appeal Convictions for Iraq Shooting UPDATED
A federal appeals court on Thursday allowed new rules restricting air pollution that crosses state lines to take effect, following up on a U.S. Supreme Court ruling that upheld the regulations in April.
A round up of news from ALM-affiliated publications and around the web: Ebola arrives in New York, a "groundbreaking" ruling on a transgender disabled veteran, contract woes for the company that greenlighted National Security Agency leaker Edward Snowden and Navy Yard shooter Aaron Alexis for security clearances and a recently obtained report on the investigation into former White House intern Monica Lewinsky's relationship with President Bill Clinton.
The Department of the Army discriminated against a civilian worker who was transitioning from male to female, the U.S. Office of Special Counsel announced Thursday. The Transgender Law Center, which represented Tamara Lusardi, called the decision “groundbreaking in its conclusion."
A San Diego company that hired "Jeopardy!" host Alex Trebek to tout its educational products settled Federal Trade Commission charges of deceptive advertising and telemarketing violations on Thursday.
Calls For Nomination
A federal judge has struck a report Takeda Pharmaceuticals U.S.A. filed with the court indicating it was on track to restore evidence in an Actos case that resulted in a $9 billion verdict.
The U.S. Court of Appeals for the Sixth Circuit has upheld a $5 million verdict issued in a mass tort in which plaintiffs alleged that GE Healthcare Inc. failed to warn that a gadolinium-based contrast agent used in MRIs can cause the growth of painful excess fibrous tissue in patients with failing kidneys.